- By Dana Sparks
New Drug Combo to Battle Thyroid Cancer
There's promising news in the battle against anaplastic thyroid cancer (ATC), a rare but aggressive and devastating form of thyroid cancer that typically strikes men and women in their 60s and 70s. The median survival is about 5 months from time of diagnosis.
Click here for news release
Sound bites with lead researcher, Keith Bible, M.D.,Ph.D., are available in the downloads above
Expert title for broadcast cg: Dr. Keith Bible, Mayo Clinic Oncologist